247 filings
8-K
SGEN
Seagen Inc.
14 Dec 23
Completion of Acquisition or Disposition of Assets
8:00am
8-K
SGEN
Seagen Inc.
12 Dec 23
Other Events
8:32am
8-K
SGEN
Seagen Inc.
1 Nov 23
Seagen Third Quarter 2023 Financial Results Reflect Strong Product Sales Growth, and Significant Portfolio and Pipeline Progress
8:09am
8-K
SGEN
Seagen Inc.
19 Oct 23
Other Events
11:14am
8-K
SGEN
Seagen Inc.
22 Sep 23
Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal
6:05am
8-K
8x2jd8
5 Sep 23
Improved Overall Survival in Patients With Recurrent or Metastatic Cervical Cancer Compared With Chemotherapy Alone
6:07am
8-K
7p6w342z
16 Aug 23
Other Events
8:15am
8-K
4a98r48
2 Aug 23
Results of Operations and Financial Condition
8:11am
8-K
022afhlv
14 Jul 23
Other Events
5:15pm
8-K
r6zmrc9lx9dbhr 05f
14 Jun 23
Other Events
6:05am
8-K
wqtpru7js71
1 Jun 23
Submission of Matters to a Vote of Security Holders
8:11am
8-K
j3wvdtkkfnm 0tx4ui1p
31 May 23
Seagen Stockholders Approve Acquisition by Pfizer
5:25pm
8-K
nnv73jtxuy0yv 0oxsts
23 May 23
Other Events
6:06am
8-K
kckhtd
15 May 23
Other Events
6:15am
8-K
5qs ilhvdumwwu2e27w
27 Apr 23
Seagen Reports First Quarter 2023 Financial Results
8:10am
8-K
cj8zsyc 8gdqaw1i1rv
3 Apr 23
Other Events
5:26pm
8-K
6zx a2xlt0g4
13 Mar 23
Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion
7:27am
8-K
bftytv z43tm
15 Feb 23
Seagen Reports Fourth Quarter and Full Year 2022 Financial Results
4:11pm
8-K
zmf0lmyuq m6835dkm
19 Jan 23
Other Events
3:37pm
8-K
uumgxnuv
18 Nov 22
Amendments to Articles of Incorporation or Bylaws
4:47pm